BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 10, 2000
View Archived Issues
Hybridon presents preclinical results with MDM2 antisense compound at AACR
Read More
ImClone Systems reports positive preclinical data from gp75 melanoma vaccine study
Read More
Celtrix receives U.S. patent for use of SomatoKine as diabetes therapy
Read More
Intranasal morphine pilot clinical trial results reported
Read More
Obesity drug slated to enter phase I trials next month
Read More
Alizyme's phase IIa trial of renzapride is fully enrolled
Read More
Hepatitis B vaccine incorporating new adjuvant requires fewer doses, has enhanced efficacy
Read More
NeoTherapeutics completes enrollment in phase IIb Neotrofin trial and initiates open-label extension
Read More
Progenics reports HIV therapy progress at Keystone symposium
Read More
Gilead licenses NX-1838, a new AMD treatment, to EyeTech
Read More
Janssen to discontinue development of R-121919 and substitute with a backup compound
Read More
Formamide compounds from Glaxo Wellcome inhibit TNF-alpha release and MMP activity
Read More
Scotia and Techniclone sign letter of intent related to licensing of VTA
Read More
New class of matrix metalloproteinase inhibitors in development by AstraZeneca
Read More
Abbott designs macrolide LHRH antagonists
Read More
Dendreon describes preparation and use of apoptosis-inducing HLA-DR-specific MAbs
Read More
Immune Network Research and Bridge Pharma expand joint venture
Read More
Novel serotonergic compounds from Cerebrus particularly useful for obesity Rx
Read More
BMS synthesizes new potassium channel blockers for cardiac arrhythmias
Read More
SkyePharma and Amgen sign development contract
Read More
Small-molecule chemokine receptor antagonists jointly developed by LeukoSite and Kyowa Hakko
Read More
Psoriatic arthritis patients sought for clinical trial
Read More
Sultams prove to be potent NNRTIs in biological screens; work presented at ACS meeting
Read More
Cogent Neuroscience secures funds to accelerate neuroprotective gene discovery program
Read More
TBC-3342: a potent urea VLA-4 antagonist designed at Texas Biotechnology
Read More
Wyeth Lederle Vaccines gains expanded access to Corixa's MPL adjuvant
Read More
Cannabinoid receptor affinity probes designed by U. of Connecticut scientists
Read More
Highly potent, non-thiol-containing FTase inhibitor characterized by BMS at AACR meeting
Read More